a retrospective re-review of all negatively adjudicated events (NAE) across three (3) protocols/studies
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Amgen, Inc.
Start Date
March 29, 2018
End Date
May 15, 2018
Administered By
Duke Clinical Research Institute
Awarded By
Amgen, Inc.
Start Date
March 29, 2018
End Date
May 15, 2018